Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Sperm acrosome associated 4 (SPACA4) is a sperm-specific, acrosomal membrane-associated protein expressed exclusively in the sperm head, where it becomes exposed during the acrosome reaction. SPACA4 is essential for sperm binding and penetration of the zona pellucida, a critical step required for mammalian fertilization. Knockout models in mice show that loss of SPACA4 leads to severely reduced male fertility, as SPACA4-deficient sperm are unable to effectively interact with and traverse the zona pellucida, despite normal motility and acrosome reaction. SPACA4 is not required for sperm–egg plasma membrane (oolemma) binding. The gene is highly conserved and appears essential for efficient mammalian gamete interaction, but there is no current evidence for direct drug interaction or established use as a biomarker or therapeutic target[1][3][4][5].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Sperm acrosome associated 4 (SPACA4).